The Science of Age-less Living

Dr. Ethan Hausman-Marquis

Welcome to The Science of Age-Less Living ! Dr. Ethan Hausman-Marquis—logevity researcher, biohacker and founder of The Catalyst Clinic—shares his journey into the fields of aesthetics, regenerative medicine, and longevity science, and offers a look at what the future of aging may hold. From his early studies at UCLA to advanced work in genomics and molecular biology at L’École Normale Supérieure in Paris and a PhD at the Karolinska Institute in Stockholm, Dr. Ethan’s path has been guided by one goal: helping people live longer, healthier, and more vibrant lives. He is the author of Exploring the World of Peptides: From Basics to Breakthroughs and Peptide-Based Cancer Therapies: A New Frontier in Precision Medicine, and has contributed to several peer-reviewed publications on cutting-edge medical research. In this episode, Dr. Ethan reflects on his transition from academic research to clinical innovation at The Catalyst Clinic—with locations in London, New York, Amsterdam, and soon Zürich—and sets the stage for what’s to come in future episodes. Each week, The Science of Age-Less Living explores the molecular and cell biology of longevity—the evolving landscape of regenerative medicine, the power of peptides, the genetics of aging, and the simple, practical tools that can help you thrive at any age. Join us as we explore what it truly means to age well—combining science, medicine, and mindset to help you live not just longer, but better. Let’s begin the journey to Age-Less Living. Learn more at: thecatalystclinic.com/wellness/peptide-therapy

  1. Tesamorelin: The Age-less Pulse of Growth Hormone | Age-Less Top 20 Peptides

    3d ago

    Tesamorelin: The Age-less Pulse of Growth Hormone | Age-Less Top 20 Peptides

    In the mid-1990s, antiretroviral therapy was transforming HIV from a death sentence into a chronic condition — and creating an unexpected syndrome in its wake. Patients on the new combinations were developing visceral fat accumulation, peripheral fat loss, dyslipidaemia, and a measurably blunted growth hormone rhythm. A small Canadian biotech in Montréal saw the lever. Native GHRH had a half-life of seven minutes, cleaved almost instantly by an enzyme called DPP-IV. Their structural innovation — adding a single trans-3-hexenoic acid group to the N-terminus — blocked the cleavage site, extended the half-life to twenty-six minutes, and made an entire pharmacology clinically viable. That compound is Tesamorelin, and in 2010 it became one of the very few synthetic peptides ever to clear the full FDA approval pathway. In this episode, Dr. Ethan walks through the molecule properly. The forty-four amino acid sequence, the structural modification that makes it work, and the mechanism that distinguishes it from every other growth hormone strategy: Tesamorelin doesn't introduce GH, it activates the body's own pituitary to release GH in its natural pulsatile pattern, preserving somatostatin feedback and the physiological rhythm that exogenous rhGH abolishes. The episode follows the cascade from GHRH receptor binding through cAMP and PKA activation to pulsatile GH release, hepatic IGF-1 production, and the anabolic and lipolytic effects downstream. Then the human evidence — and this is where Tesamorelin sits in a category of its own. Two pivotal Phase III trials, fifteen years of post-marketing data, and a defined safety profile in HIV-associated lipodystrophy. Emerging Phase II data in MASLD showing meaningful reductions in hepatic fat. Exploratory work in cognitive function, sarcopenia, and healthy ageing — promising mechanistically, but not yet pivotal-trial grade. Dr. Ethan closes with an honest 2026 assessment: what the off-label use looks like, what the safety considerations actually are, what diagnostics any responsible Tesamorelin protocol requires, and where the gap remains between mechanistic plausibility and demonstrated efficacy outside the approved population. As ever — what we know, what we don't, and what the honest picture looks like for anyone navigating this field. The Science of Age-less Living. Hosted by Dr. Ethan Hausman-Marquis. Available on Spotify and Apple Podcasts.

    25 min
  2. Klotho: The Longevity Hormone You've Never Heard Of  | Age-Less Top 20 Peptides

    May 27

    Klotho: The Longevity Hormone You've Never Heard Of | Age-Less Top 20 Peptides

    Klotho was discovered in 1997 when a disrupted gene caused mice to develop every hallmark of premature ageing within weeks — osteoporosis, arteriosclerosis, muscle wasting, cognitive decline — and die at a fraction of their expected lifespan. The inverse experiment extended lifespan by twenty to thirty percent. The protein was named after Clotho, the Greek Fate who spins the thread of life. It remains one of the most studied proteins in longevity biology nearly three decades later. In this episode, Dr. Ethan Hausman-Marquis examines Klotho from the ground up: the critical distinction between transmembrane α-Klotho and its circulating shed form sKlotho; how the FGF23 co-receptor mechanism explains the accelerated ageing phenotype of Klotho deficiency; what five separate longevity-associated pathways — including IGF-1/PI3K suppression, Wnt/β-catenin inhibition, Nrf2 antioxidant activation, and TGF-beta fibrosis suppression — suggest about why this protein matters so broadly; and why circulating Klotho levels decline by approximately 40 percent between the ages of 40 and 80. The human evidence is examined honestly: what the large prospective cohort studies actually show, what the KL-VS genetic variant data adds to the causal argument, what the 2014 Cell Reports cognitive findings mean for neurodegeneration research, and why the interventional human data — despite the extraordinary preclinical picture — is essentially non-existent. The evidence base, the interventional frontier, the exercise and vitamin D data, and the honest assessment of where exogenous Klotho research actually stands in 2026 — all of it, examined without hype. If you're researching Klotho supplementation, Klotho and ageing, Klotho and cognitive decline, or the science behind longevity peptides and anti-ageing medicine, this is the rigorous account the subject deserves. Keywords: Klotho · alpha-Klotho · sKlotho · Klotho longevity · Klotho and ageing · Klotho peptide · Klotho cognitive decline · Klotho supplement · FGF23 · longevity medicine · anti-ageing science · longevity podcast · peptide science · ageing biology · longevity research · Dr. Ethan Hausman-Marquis · The Science of Age-Less Living · The Catalyst Clinic · peptide therapy London · longevity clinic London · biohacking · epigenetics · IGF-1 · Wnt signalling · Nrf2 · TGF-beta · KL-VS · Klotho gene

    22 min
  3. Stack Smart: Supplements + Peptide Therapy for True Age-less Living

    May 14

    Stack Smart: Supplements + Peptide Therapy for True Age-less Living

    In this episode of The Science of Age-less Living, Dr. Ethan Hausman-Marquis reveals why many people using peptide therapy only achieve partial results — and how an easy, science-backed fix can unlock the missing 30–40% of their potential. He explains that peptides (such as BPC-157, CJC-1295/Ipamorelin, Thymosin Alpha-1, and collagen peptides) are powerful signaling molecules that tell your body to heal, regenerate, reduce inflammation, and optimize hormones. However, they cannot create results out of nothing. They require specific nutrient co-factors, low inflammation, and proper cellular conditions to deliver their full effects. He breaks down the key synergies between peptides and supplements, highlighting four powerful “Power Pairings”: BPC-157 + Zinc & Magnesium for superior gut healing and tissue repairCJC-1295/Ipamorelin + Vitamin D & Zinc for maximized growth hormone responseCollagen Peptides + Vitamin C for better skin, joints, and connective tissueThymosin Alpha-1 + Vitamins C, D & Selenium for stronger immune functionThe episode also covers the most common deficiencies (magnesium, Vitamin D, zinc, and omega-3s) that quietly sabotage peptide results, the importance of blood testing, and practical baseline stacks. Dr. Ethan shares how The Catalyst Clinic uses comprehensive testing, personalized analysis through their AI system AURION™, and custom-compounded daily supplement packets to make optimal stacking effortless and highly effective. Key Takeaway: Peptides signal. Supplements supply. Stack them intelligently, and you’ll move from good results to truly transformative Age-less Living.

    27 min
  4. Decoding the Blueprint – The Central Dogma, Peptides, and siRNA in the Quest for Age-less Youth

    Apr 5

    Decoding the Blueprint – The Central Dogma, Peptides, and siRNA in the Quest for Age-less Youth

    In this illuminating episode of The Science of Age-less Living, Dr. Ethan Hausman-Marquis takes you on a deep dive into the very foundation of life itself: the central dogma of molecular biology. From DNA to RNA to protein — discover how this elegant cellular assembly line governs everything from skin elasticity and energy production to repair and regeneration. Using vivid analogies, Dr. Hausman-Marquis explains why the speed and accuracy of transcription and translation are intimately linked to how we age, and how errors in this process contribute to genomic instability, protein misfolding, and inflammaging. You’ll explore the powerful roles of peptides — nature’s precision repair crews — including GHK-Cu, Epitalon, and senotherapeutic peptides like OS-01, which fine-tune protein output, support telomere maintenance, boost collagen production, and help restore youthful gene expression. Then, journey into the revolutionary world of siRNA (small interfering RNA) — the molecular silencers that can intercept and destroy faulty genetic instructions before they cause harm. Learn how this Nobel Prize-winning technology is moving from rare disease treatments into the frontier of longevity, with companies like Junevity targeting master transcription factors to reprogram aged cells. Whether you’re passionate about longevity, skincare, metabolic health, or simply want to understand how your body really works, this episode will leave you with a clearer picture of how science is transforming aging from an inevitable decline into a process we can actively influence.

    28 min

Ratings & Reviews

About

Welcome to The Science of Age-Less Living ! Dr. Ethan Hausman-Marquis—logevity researcher, biohacker and founder of The Catalyst Clinic—shares his journey into the fields of aesthetics, regenerative medicine, and longevity science, and offers a look at what the future of aging may hold. From his early studies at UCLA to advanced work in genomics and molecular biology at L’École Normale Supérieure in Paris and a PhD at the Karolinska Institute in Stockholm, Dr. Ethan’s path has been guided by one goal: helping people live longer, healthier, and more vibrant lives. He is the author of Exploring the World of Peptides: From Basics to Breakthroughs and Peptide-Based Cancer Therapies: A New Frontier in Precision Medicine, and has contributed to several peer-reviewed publications on cutting-edge medical research. In this episode, Dr. Ethan reflects on his transition from academic research to clinical innovation at The Catalyst Clinic—with locations in London, New York, Amsterdam, and soon Zürich—and sets the stage for what’s to come in future episodes. Each week, The Science of Age-Less Living explores the molecular and cell biology of longevity—the evolving landscape of regenerative medicine, the power of peptides, the genetics of aging, and the simple, practical tools that can help you thrive at any age. Join us as we explore what it truly means to age well—combining science, medicine, and mindset to help you live not just longer, but better. Let’s begin the journey to Age-Less Living. Learn more at: thecatalystclinic.com/wellness/peptide-therapy

You Might Also Like